Cost effectiveness and estimate of economical impact of immune checkpoint inhibitors for NSCLC relative to PD-L1 expression
作者： P.N. Aguiar Junior , R. De Mello , H. Tadokoro , H.M. Babiker , G. Lopes
关键词:
摘要: … are active against several neoplasms, including lung cancer. Tumor PD-L1 receptor expression is … and decreases the economical treatment burden with immune checkpoint inhibitors. …
unifesp.br
annalsofoncology.org参考文章(0)